IL-12-assisted immunization generates CD4 + T cell-mediated immunity to Listeria monocytogenes

Mice infected with virulent Listeria monocytogenes develop long-lived acquired immunity. We previously reported that acquired immunity to Listeria could also be elicited by immunizing mice with non-viable Listeria or listerial proteins/peptides in combination with IL-12. Here we show that this IL-12...

Full description

Saved in:
Bibliographic Details
Published inCellular immunology Vol. 222; no. 1; pp. 1 - 14
Main Authors Miller, Mark A., Skeen, Marianne J., Lavine, Christy L., Kirk Ziegler, H.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Inc 01.03.2003
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Mice infected with virulent Listeria monocytogenes develop long-lived acquired immunity. We previously reported that acquired immunity to Listeria could also be elicited by immunizing mice with non-viable Listeria or listerial proteins/peptides in combination with IL-12. Here we show that this IL-12-assisted immunization strategy was effective in class I but not in class II MHC-deficient mice, suggesting that antigen-specific CD4 + T cells are selectively generated using this adjuvant system. We have also evaluated the importance of endogenous production of IFN-γ and IL-12 for the efficacy of IL-12-assisted immunization. IFN-γ-deficient mice immunized with HKLM and IL-12 failed to produce effective Listeria-specific responses. In contrast, IL-12-deficient mice were able to generate protective antigen-specific T cell responses in response to immunization with HKLM and IL-12, indicating that exogenous IL-12 is sufficient to initiate a cytokine cascade that results in a potent T H1 response. IL-12-assisted immunization provides a model in which both the generation and effector mechanisms of anti-bacterial antigen-specific CD4 + effector cells can be analyzed.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0008-8749
1090-2163
DOI:10.1016/S0008-8749(03)00083-2